Medinotec (MDNC) Income from Non-Controlling Interests (2024 - 2025)
Medinotec (MDNC) posted Income from Non-Controlling Interests of -$163673.0 for Q2 2025, up 10.05% on a QoQ basis from -$181964.0 in Q2 2024, and up 10.05% year-over-year from -$148723.3 in Q2 2024.
Medinotec (MDNC) Income from Non-Controlling Interests (2024 - 2025) Analysis & Trends
Medinotec's Income from Non-Controlling Interests history runs 2 years deep, the most recent figure standing at -$163673.0 for Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.94 Bn | 176.64 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.78 Bn | 125.90 Bn | 3.81 Bn | - |
| 3 | Medtronic | 109.01 Bn | 99.79 Bn | 6.41 Bn | 16.00 Mn |
| 4 | Boston Scientific | 68.59 Bn | 67.13 Bn | 3.61 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 47.66 Bn | 43.99 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 28.36 Bn | 26.07 Bn | 1.98 Bn | 22.00 Mn |
| 7 | Dexcom | 28.30 Bn | 27.18 Bn | 750.30 Mn | - |
| 8 | Smith & Nephew | 26.93 Bn | 26.36 Bn | - | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.33 Bn | 2.07 Bn | -5.85 Mn |
| 10 | Medinotec | 58.78 Mn | 58.19 Mn | 1.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2025 | -163,673.00 |
| May 31, 2024 | -181,964.00 |